SBIR-STTR Award

Handheld and Low-cost Pulmonary Function Testing Device using Smart Coherent Multi-signal Oscillometry Technique
Award last edited on: 10/9/2022

Sponsored Program
STTR
Awarding Agency
NSF
Total Award Amount
$1,134,800
Award Phase
2
Solicitation Topic Code
SH
Principal Investigator
Gaurav Patel

Company Information

Cognita Labs LLC

6666 Harwin Drive Suite 680
Houston, TX 77036
   (949) 266-4083
   info@cognitalabs.com
   www.cognitalabs.com

Research Institution

William Marsh Rice University

Phase I

Contract Number: 1417256
Start Date: 7/1/2014    Completed: 6/30/2015
Phase I year
2014
Phase I Amount
$225,000
The broader impact/commercial impact of this Small Business Technology Transfer (STTR) Phase I project is development of a pulmonary function testing device for detection and diagnosis of pulmonary conditions. Today more than 650 million globally, nearly 10% of the world?s population, suffers from lung conditions like Asthma and Chronic Obstructive Pulmonary Disease (COPD). Currently, the most well-established method for lung function testing is spirometry, which requires the patient to conduct an unnatural breathing maneuver. In addition, spirometry cannot detect lung conditions for certain patient population. The proposed technology can be used without special breathing maneuver, and can differentiate more lung conditions than spirometer. Since the proposed device can be used while the patient is breathing normally, it will also cater to currently under-served patient segments, e.g. young children and senior citizens, for detection and diagnosis of pulmonary conditions. By targeting a portable form-factor, this technology will empower point-of-care pulmonary testing where it is currently infeasible. The proposed project will develop be the first handheld implementation of the well-studied principle of forced oscillation technique (FOT), where an acoustic pressure wave is sent via the mouth to a patient?s lungs and reflections are used to measure lung function. Thus, no special breathing maneuver is required from the patient. To achieve the handheld form-factor, the team proposes two complementary innovations. First, the team will develop a new coherent multi-speaker transmitter, which will reduce the size of the biggest component, i.e., speaker, in current implementations of FOT. To replace the huge speaker capable of generating sufficient magnitude pressure waves at very low frequencies, the team proposes to employ many small speakers with specially designed input signals such that they coherently add at the destination. Second, the team will develop coherent multi-sensor receiver to measure pressures waves from patient?s lungs which are often very small in amplitude, and interlaced with waves due to patient?s breathing. The team proposes to employ multiple sensors to measure flow and pressure of the reflected waves, such that the received signal to noise ratio can be increased by coherently processing the multiple received waveforms.

Phase II

Contract Number: 1556075
Start Date: 3/1/2016    Completed: 2/28/2018
Phase II year
2016
(last award dollars: 2018)
Phase II Amount
$909,800

The broader impact/commercial impact of this Small Business Innovation Research (SBIR) Phase II project is the development of a pulmonary function testing device for detection and diagnosis of pulmonary conditions. Today more than 650 million globally, nearly 10% of the world's population, suffer from lung conditions like Asthma and Chronic Obstructive Pulmonary Disease (COPD). Currently, the most well-established method for lung function testing is spirometry, which requires the patient to conduct an unnatural breathing maneuver. In addition, spirometry cannot detect certain lung conditions. The proposed technology will be used without special breathing maneuver, and will be able to differentiate more lung conditions than spirometer. Since the proposed device can be used while the patient is breathing normally, it will also cater to currently under-served patient segments, e.g. young children and senior citizens, for detection and diagnosis of pulmonary conditions. By targeting a portable form-factor, the proposed technology will empower point-of-care pulmonary testing where it is currently infeasible.The proposed project will develop the first handheld implementation of the well-studied principle of forced oscillation technique (FOT), where an acoustic pressure wave is sent via the mouth to a patient's lungs and reflections are used to measure lung function. Thus, no special breathing maneuver is required from the patient. Cognita Labs will adopt a modular approach for product design, and develop product-caliber advanced and integrated devices, that will include hardware, tablet app and EHR integration. The design will include all the innovations developed during Phase I to reduce the device size and cost while increasing its measurement accuracy. The proposed device will further develop and integrate a new ultra-sound based non-invasive sensor into the device to significantly reduce the cost of the consumable (disposable mouthpiece) and ultimately the cost of test. The team will also develop a new multi-resolution pre-screening test, with the objective to reduce bench time in outpatient clinics.